Drug Delivery

A-Alpha Bio lands Gates Foundation drug development grant

13-Jul-2020 By Jenni Spinner

The $800K grant will fund development of therapeutics for infectious diseases, including respiratory viruses like COVID-19, using machine learning.

Sandoz, Civica RX partner to stem shortage of generics

09-Jul-2020 By Jenni Spinner

The two companies plan to join forces in order to help healthcare providers anticipate and avoid shortages of critical injectable generic medications.

Webinar delves into drug delivery innovations

09-Jul-2020 By Jenni Spinner

Innovations in Drug Delivery Part II, a free online event on July 15, will feature novel technologies and innovative solutions to current challenges.

Weekly FDA COVID-19 updates and actions

08-Jul-2020 By Jenni Spinner

The agency continues to offer advice to pharma industry professionals during the global public health crisis, and offer advice on developing solutions.

Vantiq, RoviSys: COVID-19 shows need for advanced pharma tech

06-Jul-2020 By Jenni Spinner

Two leaders from advanced tech firms share lessons learned during the pandemic, pointing toward a need for technology to drive the future of pharma.

Thermo Scientific workflow aims to accelerate drug development

29-Jun-2020 By Jenni Spinner

The iSPA Workflow, using single-particle analysis technology, is intended to help pharmaceutical bring drugs to market faster while conserving costs.

Colorcon launches drug authentication platform

29-Jun-2020 By Jenni Spinner

The company’s SoteriaRx platform offers on-dose technology and detection services for authenticating a broad range of medications.

AI Vivo: dexamethasone shows promise as COVID-19 treatment

25-Jun-2020 By Jenni Spinner

The AI-focused pharma technology company reports researchers have determined the drug could save the lives of critically ill COVID-19 patents.

Idifarma: Spray-drying highly potent drugs a key growth factor

24-Jun-2020 By Jenni Spinner

The CDMO has begun manufacturing of highly potent APIs at a dedicated area in its GMP plant, geared toward niche products and clinical batches.

HPAPI Summit tackles trends and technology

24-Jun-2020 By Jenni Spinner

The ninth annual event, taking place in Boston mid-November, will feature industry professionals addressing manufacturing practices, regulatory updates and market trends.

Gilead gets green light for inhaled remdesivir study

23-Jun-2020 By Jenni Spinner

After receiving FDA approval, the pharmaceutical company has announced plans to launch a Phase I trial for an inhaled version of the COVID-19 treatment.